STAT3 and cancer: STATs are recognized as functional and developmental signaling regulators of MDSCs,40 and it has also been reported that STAT3 phosphorylation is inhibited by oxaliplatin treatment in a cancer cell line.39 However, we did not detect significant inhibition of STAT3 phosphorylation in oxaliplatin‐treated MDSCs (data not shown).